Trading Signals: SAGE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)(SAGE Therapeutics Inc)
| SAGE latest price $68.8700 (-1.09%) ($68.6000 - $70.6600) on Wed. Feb. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.97% (three month average) | RSI | 43 | Latest Price | $68.8700(-1.09%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SAGE advances 0.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SAGE advance at 0% a week (0% probability) IBB(53%) IWO(51%) IWC(48%) XBI(48%) IWM(47%) | Factors Impacting SAGE price | SAGE will decline at least -3.985% in a week (0% probabilities). VIXM(-33%) VXX(-14%) UUP(-7%) TLT(-7%) SHY(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.985% (StdDev 7.97%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
Resistance Level | $69.56 | 5 Day Moving Average | $68.69(0.26%) | 10 Day Moving Average | $68.07(1.18%) | 20 Day Moving Average | $69.56(-0.99%) | To recent high | -55.5% | To recent low | 14.4% | Market Cap | $3.577b | | | | SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA. |